Which HIV Test to Do and When: A Day-by-Day Guide After Possible Exposure

If you have had a possible HIV exposure and you are trying to figure out which HIV test to do and when, the answer depends almost entirely on how many days have passed since the exposure. Every HIV test has a window period — a span of time during which the virus is present in the body but the test cannot yet detect it. Testing too early can give a falsely reassuring negative result. This guide walks you through the four main types of HIV tests (HIV RNA, 4th generation Ag/Ab combo, antibody-only, and rapid tests), the critical 72-hour window for starting PEP (Post-Exposure Prophylaxis), and which test makes the most sense to do at each stage — grouped into the very early window (days 4-13), the early window (days 14-27), the standard testing window (days 28-44), and the conclusive window (day 45 and beyond). Please remember: this guide is educational. If you have had a recent possible exposure, please speak to a doctor in person — particularly if it has been less than 72 hours, when PEP is still an option.

Why Timing Matters: The HIV Testing Window Period

After HIV enters the body, it takes days to weeks before tests can reliably detect it. This delay exists because HIV tests do not look at the virus directly — they look at markers the virus or the body's immune system produces, and those markers take time to appear. The lag between exposure and the moment a test can pick up infection is called the window period.

Each type of HIV test has its own window period because each one detects a different marker:

• HIV RNA tests look for the virus's genetic material directly. RNA appears in the blood first — typically within 10 days.
• p24 antigen (a viral protein) appears next, usually around 14-18 days.
• HIV antibodies (the body's immune response) take longer to develop — typically 3 to 6 weeks, sometimes up to 12 weeks in a small number of people.

This is why a negative test taken too early does not rule out HIV infection. A test at day 5 cannot reliably exclude HIV; a test at day 45 with a 4th generation Ag/Ab combo essentially can. The rest of this guide walks through which test to choose, based on how many days have passed since your possible exposure.

One important note before you continue: if your possible exposure was less than 72 hours ago, please stop reading and contact a doctor or an emergency department immediately. There is a treatment called PEP (Post-Exposure Prophylaxis) that can substantially reduce the risk of HIV infection if started within 72 hours — see the dedicated section below.

The Four Main Types of HIV Tests

There are four main categories of HIV tests available in India, each with different sensitivity, cost, and window period. Knowing which one to ask for at each stage is the single most important decision you will make about your testing.

1. HIV RNA / NAT Test (Nucleic Acid Test)

What it detects: HIV's genetic material (RNA) directly in the blood.
Window period: approximately 10 days after exposure (can occasionally detect from 7 days).
When to use: very early after exposure, when antibody and antigen tests cannot yet detect the virus.
Limitations: expensive, not available in every lab, and a negative result still needs to be followed by a 4th gen Ag/Ab test at the standard window for confirmation.

2. HIV Ag/Ab 4th Generation (Combo Test)

What it detects: both the p24 antigen (a viral protein) and HIV antibodies in one test.
Window period: reliably from 14-18 days, with very high accuracy by day 28-45.
When to use: this is the preferred standard HIV test in modern practice. Most major labs in India, including Pathofast, use this as the primary HIV test.
Limitations: not as early as RNA but far more accessible and affordable.

3. HIV Antibody-Only Tests (3rd Generation)

What it detects: only HIV antibodies, not the antigen.
Window period: approximately 23-90 days, with most antibodies developing by 4-12 weeks.
When to use: mostly being replaced by 4th gen tests, but still used in some settings and as part of confirmatory testing.
Limitations: longer window than 4th gen tests, so misses early infections.

4. Rapid HIV Tests (Point-of-Care)

What it detects: usually antibodies (some newer rapid tests are Ag/Ab combo).
Window period: typically 3-12 weeks for older antibody-only rapid tests, shorter for newer combo rapid tests.
When to use: convenient for screening at ICTC centres, sexual health clinics, and community settings.
Limitations: any positive rapid test must be confirmed by a lab-based test. A negative rapid test within the window period is not reliable.

Post-Exposure Prophylaxis (PEP): The 72-Hour Window

If your possible HIV exposure was within the last 72 hours, the most important medical decision you can make right now is not about testing — it is about PEP (Post-Exposure Prophylaxis). PEP is a 28-day course of antiretroviral medication that, when started promptly after exposure, can substantially reduce the risk of HIV infection taking hold.

Key facts about PEP:

• Time-critical. PEP must be started within 72 hours of exposure. The sooner the better — ideally within 24 hours. After 72 hours, PEP is no longer recommended because the window of opportunity has effectively closed.
• Free at government hospitals. Under the National AIDS Control Organisation (NACO) program, PEP is available free of cost at government hospitals and designated ART centres across India. You do not need a referral — walk in and ask for PEP.
• Also available privately. Most large private hospitals and many infectious disease specialists can prescribe PEP. A 28-day course typically costs Rs. 2,000-6,000 depending on the regimen.
• It is a serious medication course. PEP usually involves three antiretroviral drugs (commonly Tenofovir, Lamivudine, and Dolutegravir) taken daily for 28 days. Side effects are usually manageable but real.
• You will still need follow-up testing. A baseline HIV test is done at the start of PEP, and follow-up testing is done at 4-6 weeks, 3 months, and sometimes 6 months after the exposure.

What counts as a PEP-worthy exposure? Sexual assault, condomless sex with a known or possibly HIV-positive partner, needlestick injuries, sharing injection equipment, or any other significant exposure to blood, semen, vaginal fluids, or breast milk from a person who is or might be HIV-positive. If you are unsure whether your exposure qualifies, go to a hospital and ask. Doctors are trained to assess this — the risk is in waiting, not in checking.

If it has been more than 72 hours since your exposure, PEP is no longer an option, but timely testing is. Continue to the band below that matches the day you are on.

How Your HIV Test Report Will Be Laid Out

Almost every Indian lab report — including reports from Pathofast — uses a simple two-line format for HIV testing. A typical 4th generation Ag/Ab combo HIV report looks like this:

Test	Result	Units	Biological Reference Interval
HIV 1 & 2 Antibodies + p24 Antigen (4th Gen)	Non-Reactive	S/Co	Non-Reactive (< 1.0)

The two most common results you will see are:

• "Non-Reactive" — this is the term used instead of "Negative." It means the test did not detect HIV antigens or antibodies. In the context of an adequate testing window, this is reassuring.
• "Reactive" — this means the test detected HIV markers. A reactive result is not the same as a confirmed HIV diagnosis. By international and Indian guidelines, any reactive screening test must be confirmed by a second independent test (typically Western Blot or HIV-1/2 differentiation assay) before HIV infection is confirmed. Do not draw conclusions from a single reactive screening test.

You may also see an S/Co value (Signal-to-Cutoff ratio) — a number that indicates how strongly the test reacted. Values below 1.0 are non-reactive; values above 1.0 are reactive, with higher numbers indicating stronger reactivity. The method (CLIA or ECLIA), sample type (serum), and the test generation (3rd or 4th gen) are typically noted in the fine print.

Very Early Window: Days 4 to 13 After Exposure

If it has been only 4 to 13 days since your possible HIV exposure, you are in the very early window. At this stage, most HIV tests are still in their blind spot — they cannot reliably detect HIV even if the infection is taking hold. Testing now with the wrong test will almost certainly give a negative result whether or not you are actually infected, which can be falsely reassuring.

This band covers exposures on day 4, 6, 8, 9, and 11 after possible contact.

What test makes sense at this stage:

• HIV RNA / NAT test — this is the only HIV test that can reliably detect infection in this window, and even it cannot detect anything before approximately day 7-10. The RNA test becomes most reliable around days 10-14.
• Day 4-9: probably too early even for RNA. Most laboratories will advise waiting at least until day 10-12 before performing an RNA test. If you test on day 5 or 6, a negative result tells you very little.
• Day 10-13: HIV RNA may be useful if there is a specific reason for very early testing (for example, planning a major surgery, considering whether to start PEP after the standard window, or significant anxiety that needs at least a tentative early answer).

What is NOT useful at this stage: a 4th gen Ag/Ab combo test, an antibody test, or a rapid test before day 14. These will almost certainly be non-reactive whether or not HIV infection is present, because the markers they look for have not yet developed.

What your doctor will usually recommend:

• If you are still within 72 hours of exposure — start PEP immediately (see the PEP section above).
• If PEP is not an option and you cannot wait, an HIV RNA test from day 10-12 onwards is reasonable, with the clear understanding that a negative result is not conclusive and must be followed up.
• A 4th gen Ag/Ab test at day 28 and again at day 45 is the standard follow-up regardless of what you do in the very early window.
• Avoid testing repeatedly during this period. Anxiety-driven repeat testing in the very early window almost never gives useful new information and tends to worsen distress.

Early Window: Days 14 to 27 After Exposure

If it has been 14 to 27 days since your possible HIV exposure, you are in the early testing window. At this stage, the 4th generation HIV Ag/Ab combo test becomes useful for the first time — the p24 antigen typically appears in the blood from around days 14-18, and HIV antibodies start to develop from around day 21 onwards.

This band covers exposures on day 15, 16, 17, 18, 19, 20, 22, and 26 after possible contact.

What test makes sense at this stage:

• HIV Ag/Ab 4th Generation Combo Test — this is the preferred test for the early window. It catches infection earlier than antibody-only tests because it also detects the p24 antigen, which appears before antibodies do.
• At day 14-18, the 4th gen test has moderate sensitivity — many infections are detectable but some are still missed.
• At day 19-27, sensitivity rises substantially. A negative 4th gen at this stage is much more reassuring than a negative test at day 15.
• HIV RNA test can still be used and remains highly sensitive in this window. If access and cost allow, an RNA test paired with a 4th gen test is the most thorough approach.

Important caveats:

• A negative 4th gen test in this window is not yet conclusive. It is reassuring but not definitive. A follow-up test at day 45 is required to be confident.
• A reactive (positive) 4th gen test at any stage must be followed by a confirmatory test — usually an HIV-1/2 differentiation assay or Western Blot — before HIV infection is considered confirmed. The screening test on its own is not the diagnosis.
• If you have any flu-like symptoms (fever, sore throat, swollen lymph nodes, rash) during days 14-28, mention this to your doctor. These can be symptoms of acute HIV seroconversion illness and may change the testing approach.

What your doctor will usually recommend: a 4th gen Ag/Ab combo test at any point in this window, followed by a confirmatory 4th gen test at day 45 regardless of the earlier result, to reach a definitive answer.

Standard Window: Days 28 to 44 After Exposure

If it has been 28 to 44 days since your possible HIV exposure, you are in the standard testing window. At this stage the 4th generation HIV Ag/Ab combo test is highly accurate, and a negative result is meaningfully reassuring — though one more confirmation at day 45 or beyond is still recommended for absolute confidence.

This band covers exposures on day 30, 32, 33, 34, 35, 36, 38, 39, 40, 41, 42, and 43 after possible contact.

What test makes sense at this stage:

• HIV Ag/Ab 4th Generation Combo Test — this is the gold standard for this window. By day 28-30, the 4th gen test detects approximately 99% of infections. By day 42, it detects close to 100%.
• If you have not yet been tested at all, a single 4th gen test in this window is the right starting point.
• If you tested earlier (in the early window) and got a negative result, repeating the 4th gen test now is the standard follow-up.

What the result typically means:

• Non-Reactive (negative): a negative 4th gen test in this window is very reassuring. The standard practice is one more test at day 45 or beyond to call the result conclusive, but the probability of HIV infection at this point is already very low.
• Reactive (positive): a reactive screening test in this window must be confirmed by a follow-up test — usually an HIV-1/2 antibody differentiation assay or a Western Blot. A single reactive screening test is not a confirmed HIV diagnosis. Repeat blood draw and confirmatory testing are essential before any conclusions are drawn.

What else is often tested at this stage: if you are testing for HIV because of a possible sexual exposure, your doctor may also recommend tests for other sexually transmitted infections that have their own window periods — including syphilis (VDRL/RPR), Hepatitis B surface antigen, Hepatitis C antibody, and depending on the exposure, screening for gonorrhoea and chlamydia.

Conclusive Window: Day 45 and Beyond After Exposure

From day 45 onwards, you are in the conclusive testing window for the 4th generation HIV Ag/Ab combo test. According to CDC guidelines, a negative 4th gen test at 45 days after exposure is considered conclusive — that is, sufficient on its own to rule out HIV infection from that exposure event. The Indian National AIDS Control Organisation (NACO) follows similar principles, with some clinicians extending the conclusive window to 90 days when an antibody-only test is used or when specific risk factors are present.

This band covers exposures on day 45 and beyond.

What test makes sense at this stage:

• HIV Ag/Ab 4th Generation Combo Test — a single negative test at day 45 or later is considered definitive in most clinical guidelines. No further testing for this exposure event is usually needed.
• If you have only had access to an antibody-only test (3rd generation), the conclusive window extends to approximately 12 weeks (84 days).
• If you have had multiple potential exposures, the clock resets with each new exposure — the 45-day rule applies from the most recent exposure, not the first.

Special situations where retesting beyond 45 days is recommended:

• If you took PEP, retesting is typically done at 3 months after finishing the 28-day course, because PEP can occasionally delay the appearance of HIV markers.
• If you have significant immune compromise (for example, advanced cancer, organ transplant, immunosuppressive medication), antibody development may be delayed and longer follow-up may be advised.
• If you had symptoms suggestive of acute HIV illness during the early window but tested negative throughout, your doctor may extend follow-up to 6 months out of caution.

A negative 4th gen test at day 45 means it is time to stop testing for this exposure and move on. Repeat anxiety-driven testing beyond the conclusive window does not provide new information and tends to prolong distress without benefit. If you are struggling with anxiety about HIV exposure despite a negative conclusive test, a conversation with a counsellor or your primary care doctor about health anxiety is often more useful than another blood test.

---